Latest filing published 05 Aug 2026 for Prestige Consumer Healthcare Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by James DArecca span 3 companies, the busiest being Haemonetics Corp, Prestige Consumer Healthcare Inc. and TherapeuticsMD, Inc. Between 10 August 2021 and 4 August 2026, the trades on record add up to 16 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 5 August 2026 came the latest disclosure, a share grant in Prestige Consumer Healthcare Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations